Brief: Oncolytics Biotech Announces CEO Matt Coffey To Take Medical Leave Of Absence
24/06/2024 12:11
June 24 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® ANNOUNCES PRESIDENT AND CHIEF
EXECUTIVE
OFFICER DR. MATT COFFEY TO TAKE MEDICAL LEAVE OF ABSENCE
Source text for Eikon: ID:nCNW9Sb4ya
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer